| Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements | Tissue Engineering - Part B: Reviews | 2012 | 213 |
| Are therapeutic human mesenchymal stromal cells compatible with human blood? | Stem Cells | 2012 | 212 |
| European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011) | Transplant Infectious Disease | 2012 | 180 |
| Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy | Human Gene Therapy | 2012 | 90 |
| Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation | European Journal of Haematology | 2012 | 57 |
| Immunomodulatory type II natural killer T lymphocytes in health and disease | Scandinavian Journal of Immunology | 2012 | 51 |
| Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma | Genetics and Molecular Research | 2012 | 40 |
| Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study | European Journal of Haematology | 2012 | 38 |
| Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions | Human Vaccines and Immunotherapeutics | 2012 | 33 |
| In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) | Free Radical Biology and Medicine | 2012 | 29 |
| Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment | Haemophilia | 2012 | 28 |
| Viral findings in adult hematological patients with neutropenia | PLoS ONE | 2012 | 27 |
| Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy | Bone Marrow Transplantation | 2012 | 27 |
| Entourage: the immune microenvironment following follicular lymphoma | Blood Cancer Journal | 2012 | 26 |
| Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution | Upsala Journal of Medical Sciences | 2012 | 25 |
| Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia | Leukemia and Lymphoma | 2012 | 24 |
| Pain and anxiety during bone marrow aspiration/biopsy: Comparison of ratings among patients versus health-care professionals | European Journal of Oncology Nursing | 2012 | 20 |
| Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide | Leukemia | 2012 | 19 |
| Hepatoblastoma in the Nordic countries | International Journal of Cancer | 2012 | 17 |
| Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia | PLoS ONE | 2012 | 16 |
| Combined chromatin and expression analysis reveals specific regulatory mechanisms within cytokine genes in the macrophage early immune response | PLoS ONE | 2012 | 15 |
| Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Data From a Dose-Escalation Phase I/II Study | Blood | 2012 | 15 |
| Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation | Cell Death and Disease | 2012 | 13 |
| Subcutaneous IgG replacement after pediatric SCT | Pediatric Transplantation | 2012 | 13 |
| Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival? | Leukemia and Lymphoma | 2012 | 11 |
